This presentation discusses the risks associated with natural rubber latex (NRL) in surgical environments, focusing on allergic reactions ranging from skin irritation to severe anaphylaxis. It highlights the prevalence of latex allergies, particularly among healthcare professionals, and the potential impact to patients.

An overview of surgical safety practices, pre-admission assessment and the importance of reducing risks and maintaining safety for patients and staff.

Discussing examples of previously published case studies, using high quality latex free sterile gloves, the presentation advocates for transitioning to latex-free surgical theatres.

This session will provide an overview of hand health and highlight the importance of infection control and double gloving in a theatre setting. It will also detail a quality improvement study aimed at enhancing standards during the routine preparation of intravenous medications.

A critical look at current practice in VTE prevention and where it differs to published guidance, to include a review of the evidence for various thromboprophyalxis modalities.

Prevention of blood clots, medically known as venous thromboembolism (VTE), is a key patient safety priority for hospitals. VTE includes both deep-vein thrombosis (DVT) and pulmonary embolism (PE), and the risk of developing VTE is highest following major surgery. All adult patients admitted to hospital need to be risk assessed for VTE according to the criteria set out in the NICE guidance, so that preventative treatments can be given. The VTE risk assessment has been included as a National Quality Requirement in the NHS Standard Contract since 2014/15. NICE published guidelines in 2018 . It provides recommendations and cost-effective measures to reduce the risk of VTE.